AzTrials
AzTrials

MeditationNCT04917081

'Go With the Flow': Effects of Mindful Self-Compassion in Psychiatric Rehabilitation

A study testing Mindful Self-Compassion and Progressive Muscle Relaxation in people with Meditation and Progressive Muscle Relaxation, run by Medical University of Graz at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is designed as a randomized controlled trial to gain further insights into possible effects of a standardized 6-week Mindful Self-Compassion (MSC) training on psychiatric rehabilitation inpatients and aims to generate insights into which parameters of mental health, and especially emotion regulation, can be… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Meditation, Progressive Muscle Relaxation
What is being tested?
Mindful Self-Compassion and Progressive Muscle Relaxation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
233 participants
Where
1 siteAustria
Study dates
11 Sep 2020to 11 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Psychiatric diagnosis
  • Signed informed consent form
  • Full command of the German language

Who cannot join

  • Age <18 years
  • Acute psychotic episode, acute suicidal tendencies, and acute addiction disorders

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • pro mente REHA, Sonnenpark Neusiedlersee

    Rust, Burgenland, 7071

Other trials in Austria

About this study

This study is designed as a randomized controlled trial to gain further insights into possible effects of a standardized 6-week Mindful Self-Compassion (MSC) training on psychiatric rehabilitation inpatients and aims

  • to generate insights into which parameters of mental health, and especially emotion regulation, can be improved by MSC in this setting,
  • to compare effects of MSC training with an established relaxation training (i.e., progressive muscle relaxation; PMR) and
  • to determine the general conditions and patient characteristics influencing the effectiveness of MSC training.
Being tested
Mindful Self-Compassion, Progressive Muscle Relaxation
Keywords
Mindful Self-Compassion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindful Self-CompassionBehavioural

    Mindful Self-Compassion has been developed by Neff and Germer as a specific kind of Mindfulness-Based Interventions to promote self-compassion. It combines the skills of mindfulness and self-compassion, providing a powerful tool for emotional resilience and enhancing the capacity for emotional wellbeing. In this study, a shortened version of the MSC program is used which is applied once a week for 75 minutes throughout the patients' stay in the rehabilitation clinic.

  • Progressive Muscle RelaxationBehavioural

    Progressive Muscle Relaxation by Jacobson is a deep relaxation technique that helps relieve muscle tension and is based on the premise that mental calmness is a natural result of physical relaxation. In this study, Progressive Muscle Relaxation is applied once a week for 75 minutes throughout the patients' stay in the rehabilitation clinic.

Study groups in NCT04917081
Study groupRoleWhat they receive
Mindful Self-CompassionExperimentalNot described
Receives: Behavioral: Mindful Self-Compassion
Progressive Muscle RelaxationActive comparatorNot described
Receives: Behavioral: Progressive Muscle Relaxation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Emotion Regulation Questionnaire (ERQ)

    The Emotion Regulation Questionnaire (ERQ) measures two common emotion regulation strategies (cognitive reappraisal and expressive suppression) with a total of 10 items (reappraisal scale: 6 items; suppression scale: 4 items), which are answered on a seven-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). The higher the score of a scale (mean value ranging from 1 to 7), the more frequently the respective emotion regulation strategy is used.

    Measured: Baseline and 1 day after the last intervention

  2. Change in Positive and Negative Affect Schedule (PANAS)

    The Positive and Negative Affect Schedule (PANAS) consists of 20 items and captures two dispositional dimensions (positive affect and negative affect), 10 items for each scale. A five-point Likert scale (1 - very slightly to 5 - extremely) is used. Mean scores for each of the two scales can range from 1 to 5, with lower scores representing lower levels of positive/negative affect and higher scores representing higher levels of positive/negative affect.

    Measured: Baseline and 1 day after the last intervention

  3. Reappraisal Inventiveness Test (RIT)

    The Reappraisal Inventiveness Test (RIT) assesses emotion regulation abilities on a behavioral level. Participants generate cognitive reappraisals for different anger-provoking situations to reduce their anger. The fluency (total number of generated nonidentical ideas that qualified as cognitive reappraisals) and flexibility (number of categorically different reappraisals) of these reappraisals are measured. The given answers will be independently rated by two researchers. In addition, the intensity of induced anger will be assessed with a seven-point Likert scale from 0 (not at all) to 6 (very).

    Measured: 1 day after the last intervention

Secondary outcomes (5)
  1. Change in Self-Compassion Scale (SCS)

    SCS captures the amount of self-compassion by means of 26 items answered on a five-point Likert scale (1 to 5). A higher value (mean value ranging from 1 to 5) indicates a higher level of self-compassion.

    Measured: Baseline and 1 day after the last intervention

  2. Change in Short-Form-Health Survey (SF-12)

    SF-12 measures quality of life via 12 items answered with different response formats. The items are weighted and summed to provide a physical and mental health score ranging from 0 to 100, with a higher score indicating better health.

    Measured: Baseline and 1 day after the last intervention

  3. Change in Brief Symptom Inventory (BSI-18)

    The BSI-18 assesses psychiatric symptoms in three dimensions (somatization, depression and anxiety), which can be summarized in a global severity index (GSI). It contains 18 items that are answered on a five-point Likert scale ranging from 0 (not at all) to 4 (extremely). Higher values (ranging from 0 to 24 in the three dimensions; ranging from 0 to 72 in the GSI) indicate a greater severity of symptoms.

    Measured: Baseline and 1 day after the last intervention

  4. Change in Multidimensional Inventory for Religious/Spiritual Well-Being 12 (MI-RSB 12)

    The MI-RSB 12 captures four different dimensions of religious and spiritual well-being, namely general religiosity, forgiveness, connectedness, and immanent hope, which can be collated into a total amount of religious/spiritual well-being (RSB). The instrument consists of 12 items, three items per dimension, answered via a six-point Likert scale (1 - strongly disagree to 6 - strongly agree). Scores range from 3 to 18 for each subscale and from 12 to 72 for the overall score of the RSB. Higher scores indicate higher religious and spiritual well-being.

    Measured: Baseline and 1 day after the last intervention

  5. Change in Happiness

    The amount of subjective happiness will be captured by one item, which has to be answered on a 10-point Likert scale, with 1 indicating "not happy at all" and 10 "absolutely happy".

    Measured: every day during the stay at the rehabilitation clinic

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2021
  2. Study start11 Sep 2020
  3. Primary completion11 Aug 2021
  4. Study completion11 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
233 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04917081
Sponsor's protocol ID
MUGrazXXX
Status last verified
Apr 2022
First submitted
27 May 2021
Last updated
6 Apr 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mindful Self-Compassion and Progressive Muscle Relaxation in people with Meditation and Progressive Muscle Relaxation, run by Medical University of Graz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Emotion Regulation Questionnaire (ERQ) (time frame: Baseline and 1 day after the last intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in